BioLargo
Stock Forecast, Prediction & Price Target
BioLargo Financial Estimates
BioLargo Revenue Estimates
BioLargo EBITDA Estimates
BioLargo Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $2.53M N/A | $5.88M 132.47% | $12.23M 107.85% | Avg: $23.5M Low: $21.5M High: $25.49M avg. 92.15% | Avg: $26.28M Low: $24.70M High: $27.85M avg. 11.82% | ||
Net Income
% change YoY
| $-7.37M N/A | $-4.49M 39.05% | $-3.50M 22.06% | Avg: $-1.42M Low: $-1.54M High: $-1.31M avg. 59.19% | Avg: $0 Low: $0 High: $0 avg. 100% | ||
EBITDA
% change YoY
| $-6.29M N/A | $-5.01M 20.43% | $-4.18M 16.46% | Avg: $-19.60M Low: $-21.27M High: $-17.93M avg. -368.39% | Avg: $-21.92M Low: $-23.24M High: $-20.60M avg. -11.82% | ||
EPS
% change YoY
| -$0.03 N/A | -$0.02 43.62% | -$0.01 26.78% | Avg: -$0.01 Low: -$0.01 High: -$0 avg. 59.34% | Avg: $0 Low: $0 High: $0 avg. 100% | ||
Operating Expenses
% change YoY
| $7.48M N/A | $7.97M 6.57% | $10.34M 29.63% | Avg: $49.88M Low: $45.63M High: $54.12M avg. 382.43% | Avg: $55.78M Low: $52.43M High: $59.13M avg. 11.82% | ||
FAQ
What is BioLargo stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 29.59% in 2025-2026.
We have gathered data from 2 analysts. Their low estimate is -1.54M, average is -1.42M and high is -1.31M.
What is BioLargo stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 51.99% in 2025-2026.
We have gathered data from 2 analysts. Their low revenue estimate is $21.5M, average is $23.5M and high is $25.49M.
What is BioLargo stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 29.67% in 2025-2026.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.01, average is -$0.01 and high is $-0.00.